Platelet necrosis mediates ischemic stroke outcome in mice.
Platelets play critical roles in maintaining hemostasis. Dysregulated platelet functions contribute to both the development and progression of ischemic stroke. Utilizing mice with a platelet-specific deletion of cyclophilin D (CypD), a mediator of necrosis, we found that platelet necrosis regulates tissue damage and outcomes during ischemic stroke in vivo. Loss of CypD in platelets significantly enhanced cerebral blood flow, improved neurological and motor functions, and reduced ischemic stroke infarct volume after cerebral ischemia/reperfusion injury in mice. These effects were attributable, at least in part, to platelet-neutrophil interactions. Twenty-four hours after stroke, significantly fewer circulating platelet-neutrophil aggregates were found in CypD-deficient mice. Mice with CypD-deficient platelets also had less neutrophils recruited to their brain relative to wildtype counterparts, and cerebral platelet-neutrophil aggregates were virtually absent in mice with CypD-deficient platelets. Neutrophil depletion in wildtype mice conferred protection from ischemic stroke similarly to mice with CypD-deficient platelets. However, neutrophil depletion in mice with CypD-deficient platelets did not further reduce infarct size. These results suggest necrotic platelets interact with neutrophils to exacerbate brain injury following ischemic stroke. As inhibiting platelet necrosis does not compromise hemostasis, targeting platelet CypD may be a potential therapeutic strategy to limit brain damage following ischemic stroke.